You are currently viewing a new version of our website. To view the old version click .

Current Oncology, Volume 30, Issue 9

September 2023 - 64 articles

Cover Story: One in eight women will be diagnosed with breast cancer (BC) over their lifetime. An accurate understanding of BC treatment cost is critical given the health system economic impacts. Activity-Based Costing (ABC) is a micro-costing method that maps patient activities along a treatment trajectory. ABC reflects evidence-based practices for treatment algorithms, clinician and patient preferences, and is effective when treatments are rapidly evolving. We use ABC to determine a per case cost for BC by stage and molecular subtype. We proportionally integrate multidisciplinary evidence-based patient and provider treatment options to yield a single case cost for the total duration of treatment. The real-time case-based nature of our model allows the actual cost of BC treatment to be better understood and compared with previous estimates. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (64)

  • Article
  • Open Access
2,498 Views
13 Pages

15 September 2023

Primary malignant cardiac tumors (PMCTs) are rare but lethal neoplasms. There are limited evidence-based treatment guidelines for PMCTs. We evaluated the relation of chemotherapy with mortality outcomes in patients with PMCTs in the United States. Da...

  • Article
  • Open Access
1 Citations
1,991 Views
11 Pages

15 September 2023

Recipients and caregivers of Hematopoietic Stem Cell Transplant (HCT) have extensive physical and psychosocial needs. HCT programs recognize the need to support psychosocial wellbeing. However, evidence-based guidance for pre-HCT psychosocial service...

  • Article
  • Open Access
1 Citations
2,407 Views
13 Pages

15 September 2023

The present study aimed to investigate the influence of the mutation abundance of the epidermal growth factor receptor (EGFR) and its co-mutation with TP53 on the therapeutic efficacy of tyrosine kinase inhibitor (TKI) treatment in patients with meta...

  • Systematic Review
  • Open Access
3,601 Views
20 Pages

15 September 2023

Despite the development of HER2-targeted drugs, achieving favorable outcomes for patients with HR+/HER2+MBC remains challenging. This study utilized Bayesian Network Meta-analysis to compare the efficacy and safety of anti-HER2 combination regimens....

  • Article
  • Open Access
8 Citations
3,602 Views
10 Pages

The Impact of Oral Antibiotics Prior to Cancer Diagnosis on Overall Patient Survival: Findings from an English Population-Based Cohort Study

  • Eleni Domzaridou,
  • Tjeerd Van Staa,
  • Andrew G. Renehan,
  • Natalie Cook,
  • William Welfare,
  • Darren M. Ashcroft and
  • Victoria Palin

15 September 2023

Background: There is limited evidence in humans as to whether antibiotics impact the effectiveness of cancer treatments. Rodent studies have shown that disruption in gut microbiota due to antibiotics decreases cancer therapy effectiveness. We evaluat...

  • Case Report
  • Open Access
1 Citations
2,061 Views
8 Pages

Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report

  • Víctor Alía Navarro,
  • Íñigo Martínez Delfrade,
  • Belén De Frutos González,
  • Blanca Morón García,
  • Ana María Barrill Corpa,
  • Pilar Sotoca Rubio,
  • Beatriz Peñas García,
  • Ana Ferrer Gómez,
  • Cristian Perna Monroy and
  • Reyes Ferreiro Monteagudo

14 September 2023

Extrapulmonary small-cell carcinoma (SCC) is a rare neoplasm that shares certain features with its pulmonary counterpart and occurs predominantly in the gastrointestinal tract (GIT). It is a high-grade and poorly differentiated neuroendocrine tumor,...

  • Article
  • Open Access
5 Citations
3,605 Views
13 Pages

Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study

  • Amanda M. Moore,
  • Zohra Nooruddin,
  • Kelly R. Reveles,
  • Paromita Datta,
  • Jennifer M. Whitehead,
  • Kathleen Franklin,
  • Munaf Alkadimi,
  • Madison H. Williams,
  • Ryan A. Williams and
  • Sarah Smith
  • + 9 authors

13 September 2023

Background: Durvalumab is approved for the treatment of adults with unresectable stage III non-small cell lung cancer (NSCLC) post-chemoradiotherapy (CRT). This real-world study describes patient characteristics and durvalumab treatment patterns (num...

  • Case Report
  • Open Access
3 Citations
2,838 Views
10 Pages

Diencephalic Syndrome: Misleading Clinical Onset of Low-Grade Glioma

  • Milena La Spina,
  • Manuela Caruso,
  • Carmela Gulizia,
  • Mattia Comella,
  • Rachele Soma,
  • Mariaclaudia Meli,
  • Piera Samperi,
  • Gregoria Bertuna,
  • Andrea Di Cataldo and
  • Giovanna Russo

13 September 2023

Background: Diencephalic Syndrome is an atypical early manifestation of low-grade gliomas; so, it is important to detect it in patients that experience a failure to thrive despite adequate length growth and food intake. The purpose of this article is...

  • Review
  • Open Access
11 Citations
3,875 Views
15 Pages

Dysregulation of Cholesterol Homeostasis in Ovarian Cancer

  • Zahraa Qusairy,
  • Anne Gangloff and
  • Shuk On Annie Leung

13 September 2023

Cholesterol plays an essential role in maintaining the rigidity of cell membranes and signal transduction. Various investigations confirmed empirically that the dysregulation of cholesterol homeostasis positively correlates with tumor progression. Mo...

of 7

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729